Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis

Published:2022-10-25 Issue:12 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Mansouri Parvin¹^ORCID,Mozafari Nikoo²³^ORCID,Chalangari Reza⁴,Martits‐Chalangari Katalin⁴

Affiliation:

1. Medical Laser Research Centers, Academic Center of Education, Culture and Research Tehran University of Medical Sciences Tehran Iran

2. Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

3. Department of Dermatology Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences Tehran Iran

4. Dermatology Department Kassir Dermatology Dallas Texas USA

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15932

Reference12 articles.

1. Chronic Urticaria

2. Chronic Spontaneous Urticaria: The Devil's Itch

3. Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria

4. Efficacy and safety of omalizumab therapy in urticaria vasculitis

5. Off-label studies on tofacitinib in dermatology: a review

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapeutics in Chronic Urticaria;Immunology and Allergy Clinics of North America;2024-08

2. Urticarial Vasculitis;Immunology and Allergy Clinics of North America;2024-08

3. A novel pitch against the itch;Indian Journal of Skin Allergy;2024-07-06

4. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment;The Lancet;2024-07

5. An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria;Indian Journal of Dermatology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3